 |
S K Sahoo, Ph.D.
Scientist
Institute of Life Sciences
Nalco Square
Bhubaneswar-751023, India
Office:
0091 674 2300137/ 2301476 ext. 221
Fax: 0091 674 2300728
Email: sanjeeb@ils.res.in,
sanjeebsahoo2005@gmail.com
|
|
Publications
Original peer-reviewed articles:
201164. Parhi
P., Mohanty C. and Sahoo S. K.: Oral delivery
and enhanced in vivo pharmacokinetics of
rapamycin loaded nanoparticles for pancreatic
cancer therapy, Actabiomateriala,
7(10):3656-69, 2011
Impact Factor-4.82
(Press)
63. Behera T., Swain P., Sahoo S. K., Mohapatra
D. and Das B.K.: “Immunostimulatory effect of
Curcumin in fish, Labio rohita, Indian J
of Natural Products and Resources, 2(2),
184-188, 2011.
62. Parveen S., Misra R. and Sahoo S. K.:
‘Nanoparticles: A Boon to Drug Delivery,
Therapeutics, Diagnostics and Imaging’
‘Nanomedicine: Nanotechnology, Biology, and
Medicine’ Nanomedicine USA.
Impact Factor-4.88.
(Press)
61. Mitra M., Misra R., Sarkar S., Krishnakumar
S. and Sahoo S. K.: EpCAM Targeted delivery of
drug loaded nano conjugate in retinoblastoma.
Molecular Vision. Impact Factor-2.6.
(Press)
60. Devilakshmi S., Palanivelu
S., Krishnakumar S., Sahoo S. K. and Verma R.
S.: Monoclonal antibody for specific targeting
of Ep-CAM in various carcinomas, Hybridoma
(Press)
59. Parveen S.
and Sahoo S. K.: Long circulating chitosan/PEG
blended PLGA nanoparticle for tumor drug
delivery, Europian J of Pharmacology
Impact Factor-2.73 (Press)
58. Acharya S. and Sahoo S. K.:
“Sustained targeting of BCR-ABL + leukemia cells
by synergistic action of dual drug loaded
nanoparticles: An implication for leukemia
therapy” Biomaterial, 32(24):5643-62, 2011,
Impact Factor-7.88
57. Misra R. and Sahoo S. K.:
“Simultaneous modulation of nuclear efflux and
drug resistance by curcumin in dual drug loaded
nanoparticles enhances the anticancer efficacy
of doxorubicin in K562 cells” Molecular
Pharmaceutics, 8(3):852-66, 2011, Impact
Factor-5.4.
56. Arya G., Vandana M., Acharaya
S. and Sahoo S. K.: “Enhanced Antiproliferative
Activity of Herceptin (HER 2) - conjugated
Gemcitabine loaded chitosan nanoparticle in
pancreatic cancer therapy” Nanomedicine USA,
Impact Factor-4.88 (Press)
55.
Singh A., Dilnawaz F. and Sahoo S. K.: Composite
polymeric magnetic nanoparticles for targeted
and controlled co-delivery of hydrophobic and
hydrophilic drugs in cancer therapy. Submitted
to ACS Applied Material and Interface,
3(3):842-56, 2011, Impact Factor-2.9.
Citation: 2
54. Behera
T., Swain P. and Sahoo S. K.:
Antigen in chitosan coated liposomes enhances
immune responses through parenteral
immunization. International Immunopharmacology.
11(8):907-14, 2011, Impact Factor-2.4
53. Mitra M., Dilnawaz F., Misra R., Sarkar S.,
Krishnakumar S. and Sahoo S. K.: Toxicogenomics
of nanoparticulate delivery of etoposide:
Potential impact on nanotechnology in
retinoblastoma therapy. Cancer Nano (Press)
52. Acharya S. and
Sahoo S. K.: PLGA nanoparticles containing
various anticancer agents and tumor delivery by
EPR effect, Advanced Drug Delivery Reviews, 63,
170-183, 2011, Impact Factor-13.57.
Citation: 5
51. Das M., Dilnawaz F. and Sahoo S. K.: Targeted
nutlin-3a loaded nanoparticles inhibiting p53-MDM2 interaction: Novel
strategy for breast cancer therapy. Nanomedicine (Lond).
(3):489-507, 2011, Impact Factor- 6.2
50. Das M. and Sahoo S. K.: Epithelial cell
adhesion molecule targeted nutlin-3a loaded
immunonanoparticles for cancer therapy.
Acta Biomater.
(1):355-69. 2011, Impact
Factor-4.82 Citation: 4
49. Mohanty C., Das
M., Kanwar J. R and Sahoo S. K: Receptor
mediated tumor targeting: An emerging approach
for cancer therapy, Curr Drug
Deliv. ;8(1):45-58.
2011, Impact Factor-2.6. Citation: 4
48. Parveen S. and Sahoo S. K.:
“Evaluation of Cytotoxicity and Mechanism of
Apoptosis of Doxorubicin using Folate Decorated
Chitosan Nanoparticles for Targeted Delivery to
Retinoblastoma” Cancer Nano (1) 47-62, 2011
2010
47. Behera A. L.,
Patil S.V. and Sahoo S. K.: Nanosizing of Drugs-APromising
Approach for Drug Delivery: A Review”
International Journal of Pharmacology and
Technology, 2(1), 45-56, 2010
46. Vandana M. and Sahoo S. K.: “Long
circulation and cytotoxicity of PEGylated
gemcitabine and its potential for the treatment
of pancreatic cancer.” Biomaterials, 31,
9340-9356, 2010. Impact Factor-7.88
Citation: 6
45. Misra R., Acharya S. and Sahoo S. K.:
Cancer Nanotechnology: Application of
Nanotechnology in cancer therapy, diagnosis and
imaging. Drug Discovery Today.15,19-20, 842-850,
2010. Impact Factor-6.4 Citation: 5
44. Mohanty C. and Sahoo S. K : The in vitro
stability and in vivo pharmacokinetics of
curcumin prepared as an aqueous nanoparticulate
formulation..
Biomaterials, 31(25), 6597-611, 2010
Impact Factor-7.36 Citation: 8
43. Singh A., Misra R., Mohanty C. and Sahoo S.
K.: Applications of Nanotechnology in Vaccine
Delivery” “International Journal of Green
nanotechnology: Biomedicine,
2:B25-B45, 2010 , Citation:1
42. Mohanty A. K,
Dilnawaz F. and Sahoo S. K: Etoposide-loaded
biodegradable amphiphilic methoxy (poly ethylene
glycol) and poly (epsilon caprolactone)
copolymeric micelles as drug delivery vehicle
for cancer therapy. Drug Delivery, 17(5), 1-13,
2010 Impact Factor-2.6 Citation: 1
41.
Parveen S., Mitra M., Krishnakumar S. and Sahoo
S.K: Enhanced Antiproliferative Activity of
Carboplatin loaded Chitosan Nanoparticles in
Retinoblastoma Cell Line, Acta Biomaterialia, 6,
3120-3131, 2010, Impact Factor-4.82,
Citation: 6
40. Dilnawaz F.,
Singh A., Mohanty C. and Sahoo S. K: Dual
drug loaded superparamagnetic iron oxide
nanoparticles for targeted cancer therapy.
Biomaterials, 31, 3694-3706, 2010, Impact
Factor-7.88, Citation: 20
39. Mohanty C.,
Acharya S., Mohanty A.K, Dilnawaz F., and
Sahoo S.K Curcumin encapsulated MePEG/ PCL
block copolymeric micelles: A novel controlled
delivery vehicle for cancer therapy.
Nanomedicine, 5(3), 433-449, 2010, Impact
Factor-6.2, Citation: 11
38.
Misra R. and Sahoo S.K: Intracellular
trafficking of nuclear localization signal
conjugated nanoparticles for cancer therapy.
Submitted to European J of Pharmaceutical
Sciences, 39, 152-163, 2010, Impact
Factor-3.29, Citation:20
37. Behera T., Nanda
P. K.,
Mohanty C., Mohapatra D., Swain P.,
Das B. K., Routray P., Mishra B. K. and Sahoo
S. K.. Parenteral immunization of fish,
Labeo rohita with Poly D, L-lactide-co-glycolic
acid (PLGA) encapsulated antigen microparticles
promotes innate and adaptive immune responses.
Fish and Shellfish Immunology, 28, 320-325,
2010, Impact Factor-3.04
36. Mohanty C., Acharya S.
and Sahoo S. K.: Micelle: The
Multifunctional Nanocarrier for Colloidal Drug
Delivery in "Colloids in Drug Delivery"
(Edited by Prof. Monzer Fanun ) published by
Taylor and Francis/CRC Press,
157-176, 2010.
35. Dilnawaz F., Acharya
S., Misra R., Singh A. and Sahoo S. K.:
Nanotechnology and Drug delivery in “Bionanoscience,
Nanorobotics, and Nanomedicine”
(Edited by Prof. Klaus Sattler) published by
Taylor & Francis, 27-19, 2010
2009
34. Mohanty C., Arya G., Verma R. S. and
Sahoo S. K,
Nanobiotechnology: Application of Nanotechnology
in Therapeutics and Diagnosis, International
Journal of Green Nanotechnology: Biomedicine, 1:
B24-B38, 2009, Citation:1
33. Vandana M. and Sahoo S. K:
Optimization of physicochemical parameters
influencing the fabrication of protein-loaded
chitosan nanoparticles, 4(7), 373-785, 2009.
Citation: 4, Impact Factor:6.2,
Citation: 5
32. Acharya S., Dilnawaz F. and Sahoo S. K
: Targeted EGFR-nanoparticle bioconjugates
for breast cancer therapy, Biomaterials, 1-14,
2009.
Impact Factor:7.88,
Citation: 34
31. Misra R., Acharya S., Dilnawaz F. and
Sahoo S. K : Sustained antibacterial
activity of Doxycycline loaded poly (D,
L-lactide-co-glycolide) and poly epsilon
caprolactone nanoparticles. Nanomedicine, 4(5),
519-530, 2009.
Impact Factor:6.2,
Citation:15
30. Das M. Mohanty C. and Sahoo S.K,
Ligand-based targeted therapy for cancer tissue,
Export Opinion in Drug Delivery, 6, 285-304,
2009.
Impact Factor:3.34,
Citation:19
29. Baratchi S., Kaur R. K., Khoshmanesh, Vasu
P., Ashok C., Hittu M., Parratt A., Krishnakumar
S., Sun X., Sahoo S. K
and
Kanwar J. R.,
Promises of Nanotechnology for Drug Delivery to
Brain in Neurodegenerative Diseases,
Current Nanosciences,
5, 15-25, 2009.
Impact Factor:1.47,
Citation:17
2008
28. Dilnawaz F. and Sahoo S. K,
Nanotechnology and its Impact on Aquaculture in
Applied Bioinformatics, Statistics and
Economics in Fisheries Research (Eds. A.K
Roy & Niranjan Sarangi), New India Publishing
Agency, New Delhi, 247-259, 2008
27. Reddy M. K., Vasir J. K., Sahoo S. K,
Jain T. K., Yallapu M. M., Labhasetwar V.
Inhibition of Apoptosis Through Localized
Delivery of Rapamycin-Loaded Nanoparticles
Prevented Neointimal Hyperplasia and
Reendothelialized Injured Artery, Circulation
Cardiovascular Intervention, 1, 209-216,
2008. Impact Factor: 2.8, Citation:8
26.
Horning
J. L.,
Sahoo S. K.,
Vijayaraghavalu
S.,
Dimitrijevic S.
,
Vasir
JK,
TK
Jain
,
Panda
A. K,
Labhasetwar
V.:
3-D Tumor Model for In
Vitro Evaluation of Anticancer Drugs.
Mol Pharm.
2008. Impact Factor:5.4, Citation:42
25. Potala S., Sahoo S. K, Verma R.:
Targeted therapy of cancer using diphtheria
toxin- derived immunotoxins. Drug Discov
Today. 13(17-18):
807-15, 2008.
Impact Factor:6.4, Citation:20
24. Parveen S. and
Sahoo S. K, Polymeric Nanoparticles for
Cancer Therapy. Journal of Drug Targeting,
16(2):108-23,
2008. Impact Factor:2.49,
Citation:42
23. Sahoo S. K,
Dilnawaz F and Krishnakumar K.: Nanotechnology
in Ocular Drug Delivery: Drug Discovery
Today,
13(3-4) 144-151,
2008. Impact Factor:6.4, Citation:62
2007
22. Sahoo S. K., Parveen S. And Panda J. J.,
The present and future of nanotechnology in
Human Health Care. Journal of Nanomedicine:
nanotechnology, Biology and Medicine,
3(1):20-31, 2007. Impact Factor: 4.88,
Citation:73
21. Sahoo S.K, Jain T., Reddy M. K.,
Labhasetwar V.: Nano-sized Carriers for Drug
Delivery, in “Nanobiotechnology”, (Eds. Oded
Shiseyov and Elan Levy), Humana Press, Totowa,
NJ, 329-348, 2007
20. Sahoo S. K
and Labhasetwar V.;
Biodegradable PLGA
nanoparticles for anticancer therapy in
“Nanotechnology for Cancer Therapeutics” (Ed.
Amiji M). CRC Press, 243-250, 2007.
2006
19.
Parveen S., Krishnakumar K. and Sahoo S. K., New
Era in Health Care: Tissue Engineering. Journal
of Stem Cells & Regenerative Medicine, (Invited
review for the inaugural issue), 1(1),
2006.
18. Parveen S., Sahoo S. K. ,
Nanomedicine: Clinical applications of
Polyethylene Glycol Conjugated Proteins and
Drugs, Clinical Pharmakokinetics, 45(10):
965-88, 2006. Impact Factor:4.51,
Citation:30
2005
17.
Sahoo S. K., and Labhasetwar V.;
Nanoparticle
Interface: An Important determinant in
nanoparticle- mediated drug/gene delivery. In
“Nanoparticle Technology for drug delivery”
(Ed. Gupta and Kompella), Taylor & Francis
Group, New York, 139-160, 2005.
16. Sahoo S. K., Applications of
Nanomedicine. Asia Pacific Biotech News,
9(20), 48-50, 2005, Citation:2
15. Sahoo S. K., and Labhasetwar V.;
Enhanced antiproliferaive activity of
Transferrin conjugated paclitaxel nanoparticles
is mediated via sustained intracellular drug
retention.
Molecular Pharmaceutics, 2(5), 373-383, 2005.
(Listed on NCI web site under NCI Alliance for
Nanotechnology in Cancer). Impact Factor 5.4,
Citation:90
14. Tapan K. Jain, Morales M.A., Sahoo S K.,
D. L. Leslie-Pelecky and Labhasetwa V;
Iron Oxide Nanoparticles for Sustained Delivery of
Anticancer Agents.. Mol. Pharm,
2(3),194-205, 2005, (Listed on NCI web site under NCI Alliance for
Nanotechnology in Cancer). Impact Factor 5.4, Citation:253
13. Sahoo S. K., Panda A. K and
Labhasetwar V.; Characterization of porous PLGA/PLA
microparticles as a scaffold for three
dimensional growth of breast cancer cells
Biomacromolecules, 6(2), 1132-39, 2005.
Impact Factor 5.32, Citation:47
2004
12. Sahoo S. K., Ma W.
and
Labhasetwar V.; Efficacy of a transferrin-conjugated
paclitaxel loaded nanoparticles in a murine
model of prostate cancer.
Int. J. of Cancer. 112, 335-340, 2004.
(Listed on NCI web site under NCI Alliance for
Nanotechnology in Cancer). Impact Factor
4.92, Citation:75
2003
11. Sahoo S. K., and Labhasetwar V.;
Nanotech approaches in drug delivery and
imaging. Drug Discovery Today. 8 (24),
1112-1120, 2003. (Invited Review, Listed as
top-three most down loaded article by Drug
Discovery during Sept 2003 to Sept 2004)
Impact Factor 6.4, Citation:259
10. Sawa T., Sahoo S. K. and Maeda H.;
Water-soluble polymer therapeutics with a
special emphasis on cancer chemotherapy,
Arshady R, editor, in: Polymeric Biomaterials,
The PBM Series, Vol 1: Introduction to Polymeric
Biomaterials, Citus Books, London 2003. 233-61.
9. Panayam J., Dhali M. P., Sahoo S. K,
Ma W., Chakravarthi S., Amidon A. G., Levy R. J.
and Labhasetwar V.; Polymer degradation and in
vitro release of a model protein from poly (D,L-lactide-co-glycolide)
nano- and microparticles. J. of Control.
Release. 92, 173-187, 2003. (Most
downloaded article April 2003-March 2004 in
Pharmaceitical Sciences). Impact
Factor 7.16,
Citation:123
8. Panyam J., Sahoo S. K, Prabha S.,
Labhasetwar V.; Fluorescence and Electron
microscopy probes for poly (D,L-lactide-co-glycolide)
Nanoparticles.
Int. J. Pharm, 262(1-2):1-11, 2003.
(Most downloaded article April 2003-March 2004
Pharmaceitical Sciences). Impact
Factor 3.6,
Citation:114
7. Fang J., Sawa T., Akaike T., Akuta T.,
Sahoo S. K, Khaled G., Hamada A., and Maeda
H.; In vivo antitumor activity of pegylated zinc
protoporphyrin: targeted inhibition of heme
oxygenase in solid tumor ; Cancer Research,
63(13):3567-74, 2003. Impact Factor
8.2, Citation:121
6. Bharali D. J., Sahoo S. K.,
Majumudar S. and Maitra A. N.; Cross-linked
polyvinylpyrrolidone nanoparticles: a potential
carrier for hydrophilic drugs; J. Colloid and
Interface Sci., 258(2),415-423, 2003.
Impact Factor 3.06,
Citation:33
2002
5. Sahoo S. K, Panayam J., Prabha S and
Labhasetwar V.; Residual polyvinyl alcohol
associated with poly (D, L-lactide-co-glycolide)
nanoparticles affects their physical and
cellular uptake properties J. Control.
Release. Vol. 82,105-114, 2002. Impact
Factor 7.16, Citation:258
4. Sahoo S. K., Sawa T., Fang J., Tanaka
S., Akaike T. and Maeda H.;
PEGylated Zinc protophorphyrin: a water-soluble
hemeoxygenase inhibitor with tumor targeting
capacity. Bioconjugate Chemistry, 13 (5),
1031-1038, 2002.
Impact Factor
5.0,
Citation:62
3. Panyam J., Zhou W. Z., Prabha S.,
Sahoo S. K.
and Labhasetwar V.; Rapid endo-lysomal escape of
poly (D, L-lactide-co-glycolide) nanoparticles:
implication for drug and gene delivery. The
FASEB Journal, Vol. 16, 1217-1226, 2002.
Impact Factor 6.7,
Citation:345
2000
2. Gaur U., Sahoo S. K., De T. K.,
Ghosh P.C, Maitra A.N.
and Ghosh P. K.; Bio-distribution of
fluoresceinated dextran using novel
nanoparticles evading reticuloendothelial
system, Int. J. Pharm., 202, 1-10, 2000.
Impact Factor
3.6,
Citation:113
1998
1.
Sahoo S. K.,
De T. K., Ghosh P. K.
and Maitra A.N.; pH & thermo-sensitive hydrogel
nanoparticles; J. Colloid and Interface
Sci., 206, 361-368, 1998.
Impact Factor 3.06,
Citation:44
PATENTS & PENDING APPLICATIONS:
-
Maitra AN, Ghosh PK, De TK and Sahoo SK.
Process for the preparation of highly
monodispersed polymeric hydrophilic
nanoparticles. U.S patent No. 5,874,111,
Japan patent No 330406/98, European patent
No. 973031271 Indian patent Application
no. 2350/DEL/96 dated 20 Dec, 1996.
-
Maitra AN, Ghosh PK, Sahoo SK and
Dabur Research Foundation, Sahibabad,
Ghaziabad-201010, India. Formulation of
paclitaxel, its derivatives or its analogs
entrapped into Nanoparticles of polymeric
micelles. U. S.-patent No 6, 322817 B1.
-
Maitra AN, Ghosh PK, Sahoo SK and
Dabur Research Foundation, Sahibabad,
Ghaziabad-201010, India. A Process for the
preparation of pharmaceutical formulation of
paclitaxel entrapped in to polymeric
micelles nanoparticles for the treatment of
cancer Applied for Indian patent No
263/DEL/99 dated 17Feb, 1999.
-
Labhasetwar V, Sahoo SK and Reddy MK:
Sustained release nanoparticle composition
and methords for using the same. University
of Nebraska Medical Center, Omaha, NE, USA.
US patent no- US 7,727, 554 B2
-
Labhasetwar V, Sahoo SK: Transferrin
conjugated nanoparticles for increasing
efficacy of a therapeutic agent.
University of Nebraska Medical Center,
Omaha, NE, USA. US patent Application
No-11/124, 934, filled on 9th May, 2005.
-
Sahoo S. K,
Dilnawaz F and Singh A: A methord for
preparing a water dispersible magnetic
nanoparticle formulation and use the same.
Indian Patent Application No 779/KOL/2009 of
21/5/2009 and International PCT Application
No.PCT/IN09/000639 of 12/11/2009.
-
Sahoo SK
and Mohanty C: A novel water soluble
curcumin loaded nanoparticulate system for
cancer therapy. Indian Patent
Application No 164/KOL/2010 of 22/2/2010,
International PCT Application No.PCT/IN2010/000618
of 26/10/2010.
-
Sahoo SK
and Mohanty C: A process for preparing
curcumin encapsulated chitosan-Alginate
sponge useful for wound healing.
Indian Patent Application No 1189/KOL/2010
of 27/10/2010, International PCT Application
No. PCT/IN2010/000813 Dt.14.1.2011
-
Sahoo SK and
Vandana M: A water soluble
PEGylated pemetraxed and a process for the
same. Indian Patent Application No 1405/KOL/2010
of 18/12/2010
-
Sahoo SK,
Pardhi P and Mohanty C: Drug delivery
formulation of rapamycin in the form of
polymeric nanoparticles. Indian Patent
Application No-38/KOL/2011
-
Sahoo SK and Vandana M: A water
soluble polymeric drug formulation and a
process for the same. Indian Patent
Application No 77/KOL/2011 of 20/1/2011
|